Mitsu Chem Plast Ltd Q1 FY2027 Concall Summary

Key Takeaways

• Margin transformation, not just a good quarter: EBITDA margin expanded 1,041 bps YoY to 16.29%, driven by deliberate product rationalization, operating efficiency, and a shift in focus from top line to bottom line.
• Revenue growth is steady but needs to accelerate: Total income grew 11.62% YoY in a seasonally weak quarter, but the quarterly run-rate must climb from ~₹95 crores toward ₹120–130 crores to stay on track for the FY28 target.
• A new product cycle is beginning: The IBC project is expected to start commercial production in Q3 FY27, representing a bet on a new-to-the-company market that management itself says will need to "test the water."
• Capacity is being added ahead of demand: 3,550 MTPA of new capacity is already operational, funded with ~₹2 crores of capex, even though FY26 utilization averaged only 60–64% and post-expansion utilization is guided to a similar 64–70% range.
• What to watch next quarter: Whether the quarterly revenue run-rate meaningfully accelerates toward the ₹120–130 crores needed for the FY28 target, the pace of new customer conversion from the 30+ added in Q1, and any concrete disclosure on IBC capex and revenue contribution.

The Margin Reset: From Survival to Structure

• Product rationalization is the core driver: The company is actively discontinuing low-margin, low-throughput, profit-drainer products and replacing them with new, higher-margin introductions, a process that has been visibly improving margins since Q3.
• Operating efficiency is compounding the mix shift: Management attributes the sustained improvement to operating efficiency, value addition, and value engineering, not merely to favorable raw material price movements.
• Raw material is a pass-through with a lag: The company stopped importing raw materials years ago, buys locally from Indian producers, and operates on a cost-plus markup model where raw material is a pass-through, with price increases generally passed to customers within one month.
• Margin volatility is structural, not anomalous: Some products carry very high margins while others sit at 10–12%, so quarter-to-quarter EBITDA will fluctuate; management speaks on an average basis and guides sustainable margins at 10–13%.

Manish Dedhia: "We are going away with many of the products which are not good profit margin or drainer, profit drainer. So definitely, we are closing that product."

The ₹1,000 Crore Ambition: Target vs. Trajectory

• The FY28 target remains the North Star: Management reaffirmed the long-term objective of achieving ₹1,000 crores in annual revenue by FY28, but acknowledged the quarterly run-rate must accelerate from ~₹95 crores to ₹120–130 crores to get there.
• Growth is promised "very soon": Management stated the required revenue growth will be visible "very soon," driven by the IBC project and the newly operational 3,550 MTPA capacity expansion, but provided no quantified ramp schedule.
• The bottom-line pivot is explicit: Management has repeatedly stated over the past year that the focus is now more on bottom line than top line, a stance that may temper the pace of revenue acceleration if margin-dilutive volume is rejected.
• Revenue mix is expected to stay 80-20: Even at the ₹1,000 crores milestone, packaging (containers) is expected to remain the largest contributor at roughly 80% of the business, with furniture parts and others at 20%, though furniture parts are targeted for bigger growth.

Manish Dedhia: "As I always mentioned in my con call till now since last 1 year, that we always -- now we are more focusing on bottom line rather than top line."

IBC: The Next Bet, With Open Questions

• A new product in a new market: The Intermediate Bulk Container (IBC) project is a completely new product line for Mitsu, requiring entirely separate machinery from the existing blow molding and injection molding setup, with commercial production expected around Q3 FY27.
• Management is cautious in its own language: The opportunity is described as good but unproven, with management stating "once we come up with that and then you'll have to test the water," signaling that revenue contribution and market acceptance are uncertain.
• Capex remains undisclosed: The investment amount for the IBC project has not been revealed; management said it will be announced "very soon," leaving investors unable to size the bet or assess the return profile.
• Lead times force early capacity decisions: Blow molding and injection molding machinery carries a 6–9 month lead time from order to commercialization, so management argues it must plan capacity ahead of confirmed demand, with infrastructure already in place.

Manish Dedhia: "It's a good opportunity. It's a new product in the market. And as a management, we are seeing a good opportunity in this particular market. But once we come up with that and then you'll have to test the water."

Capacity Expansion: Adding Supply Before Demand

• 3,550 MTPA is already live: The new capacity, announced after a successful trial run, is operational across all three product verticals (containers, furniture parts, others) and was funded with approximately ₹2 crores from a mix of internal accruals and debt.
• Utilization math raises a question: FY26 overall utilization was 60–64%, with Q1 and Q2 of last year being very low, and post-expansion utilization is guided to a similar 64–70% range, which management considers healthier, implying the new capacity is not being added to relieve a bottleneck.
• A new unit was also added recently: One more unit was taken in the January/February timeframe (last quarter of FY26), adding to the capacity base ahead of the demand curve.
• The rationale was cut off: When an analyst asked why capacity is being added at 64% utilization, management was interrupted mid-response and the answer was not completed in the transcript, leaving the strategic logic partially unexplained.

Customer & Demand Landscape

• Customer acquisition is active: The company added 30+ new customers in Q1 FY27 and 150+ in the full previous year, while also managing existing relationships for better throughput, profitability, and turnover.
• All verticals are seeing higher demand: Management reported good profitability and incremental opportunity across containers, furniture parts, and other verticals, with furniture parts and healthcare (Furnastra brand) targeted for bigger growth going forward.
• Exports remain a slow burn: The company has entered international markets but results are "still awaiting," with management describing it as an ongoing process that takes a lot of time and offering no timeline for material contribution.
• Pricing power exists but is constrained: Raw material price increases are passed through to customers, who management says understand the geopolitical situation, but the arrangement is fundamentally a cost-plus markup where raw material is a pass-through, limiting structural margin upside from price.

Manish Dedhia: "Customers are also understanding that if this is a problem and then if they do not give a price increase, we will not be able to supply because not be able to supply in the loss."

Capital & Investor Base

• A small warrant issue was completed: Rikhav Securities Limited was allotted 2 lakh warrants as a non-promoter allottee purely as an investor, with no existing investment, business, or advisory relationship with Mitsu; proceeds will be used for working capital.
• Small-company fundraising remains a challenge: Management acknowledged that small companies always face challenges getting investors, framing the warrant allotment as a small but notable step in broadening the investor base.

Manish Dedhia: "It is a very, very -- a small company is always a challenge to get the investor."

Guidance & Commitments

Key Metrics